BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Protox Therapeutics Inc. (PRX.V) Announces Manufacturing Agreement with Dompe for PRX321


7/17/2007 3:23:52 PM

VANCOUVER, July 17 /CNW/ - Protox Therapeutics Inc. (TSX-V:PRX) announced today that it has entered into an agreement with Dompé pha.r.ma S.p.A. (Dompé) for clinical manufacture and commercial supply of PRX321, its lead product candidate in development for the treatment of primary brain cancer. Under the terms of the agreement, Dompé will manufacture PRX321 according to current Good Manufacturing Practice at its state-of-the-art facility in Italy for the upcoming pre-pivotal clinical trial and has committed to supply commercial batches for a period of 5 years following product registration. Terms of the final agreement have not been released.

Read at Canada NewsWire

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES